ArticleGenetics in medicine open2026
RecQ DNA helicases germline variants in Lynch-like syndrome.
Article in Genetics in medicine open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Lynch-like syndrome (LLS) is associated with an incomplete understanding of its molecular basis. Some LLS tumors harbor somatic variants in mismatch repair genes, whereas germline variants in other DNA repair genes point to a hereditary predisposition in certain cases. Clinically, LLS patients tend to develop colorectal cancer (CRC) earlier, have a stronger family history of CRC, and respond better to immunotherapy compared with sporadic CRC cases. This study seeks to identify cancer-susceptibility genes in LLS patients, which could affect diagnosis, treatment, and surveillance. Methods: Germline exome sequencing was performed on 102 participants, including 14 previously reported cases. In vitro models were created to study the effect of loss-of-function (LoF) variants in DNA repair genes. Gene/protein expression was evaluated using quantitative real-time PCR and Western blotting, and DNA repair capacity was assessed via H2AX phosphorylation after ionizing radiation exposure. Results: Nine rare LoF variants were identified in DNA repair genes, including 3 in RecQ DNA helicases ( Conclusion: A single LoF variant in RecQ DNA helicase genes can result in significant DNA repair deficiency, leading to genomic instability and contributing to CRC development in LLS. Therefore, we present evidence for incorporating
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.